Cargando…
A N(7)-Methylguanine-Related Gene Signature Applicable for the Prognosis and Microenvironment of Prostate Cancer
BACKGROUND: Despite the constant iteration of small-molecule inhibitors and immune checkpoint inhibitors, PRAD (prostate adenocarcinoma) patients with distant metastases and biochemical recurrence maintain a poor survival outcome along with an increasing morbidity in recent years. N(7)-Methylguanine...
Autores principales: | Mei, Wangli, Jia, Xuyang, Xin, Shiyong, Liu, Xiang, Jin, Liang, Sun, Xianchao, Zhang, Jia-Xin, Zhang, Bihui, Yang, Guosheng, Chen, Ping, Ye, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122703/ https://www.ncbi.nlm.nih.gov/pubmed/35602299 http://dx.doi.org/10.1155/2022/8604216 |
Ejemplares similares
-
Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer
por: Jin, Liang, et al.
Publicado: (2022) -
Computer classification and construction of a novel prognostic signature based on moonlighting genes in prostate cancer
por: Mei, Wangli, et al.
Publicado: (2022) -
A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma
por: Mei, Wangli, et al.
Publicado: (2022) -
Ubiquitin-related lncRNAs: The new tool for prognosis prediction in prostate cancer
por: Liu, Xiang, et al.
Publicado: (2022) -
In Silico Establishment and Validation of Novel Lipid Metabolism-Related Gene Signature in Bladder Cancer
por: Sun, Xianchao, et al.
Publicado: (2022)